TY - JOUR
T1 - Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera
T2 - A Real-World Analysis of Veterans Health Administration Data
AU - Parasuraman, Shreekant
AU - Yu, Jingbo
AU - Paranagama, Dilan
AU - Shrestha, Sulena
AU - Wang, Li
AU - Baser, Onur
AU - Scherber, Robyn
N1 - Publisher Copyright:
© 2019 The Authors
PY - 2020/2
Y1 - 2020/2
N2 - Patients with polycythemia vera (PV) have a substantial risk of thrombotic events (TEs). In the present retrospective analysis using Veterans Health Administration claims data, 25% of 1565 patients experienced a TE during follow-up. We observed a positive, significant association between white blood cell (WBC) counts ≥ 8.5 × 109/L and TE occurrence (reference, WBC count < 7.0 × 109/L), supporting continued inclusion of WBC count control in disease management.
AB - Patients with polycythemia vera (PV) have a substantial risk of thrombotic events (TEs). In the present retrospective analysis using Veterans Health Administration claims data, 25% of 1565 patients experienced a TE during follow-up. We observed a positive, significant association between white blood cell (WBC) counts ≥ 8.5 × 109/L and TE occurrence (reference, WBC count < 7.0 × 109/L), supporting continued inclusion of WBC count control in disease management.
KW - Leukocytosis
KW - Retrospective analysis
KW - Thrombosis
KW - White blood cell count
UR - http://www.scopus.com/inward/record.url?scp=85076827331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076827331&partnerID=8YFLogxK
U2 - 10.1016/j.clml.2019.11.010
DO - 10.1016/j.clml.2019.11.010
M3 - Article
C2 - 31865003
AN - SCOPUS:85076827331
SN - 2152-2650
VL - 20
SP - 63
EP - 69
JO - Clinical Lymphoma, Myeloma and Leukemia
JF - Clinical Lymphoma, Myeloma and Leukemia
IS - 2
ER -